Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Heeringa

Showing results (21-30 of 171) with videos related to

Pageof 18
Sort By:
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the plenary session: cellular and molecular mechanisms of disease (I)Jonas Zimmermann, Adrian Schreiber, Peter Heeringa, et al.
Plos One|March 26, 2011
Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitisHenko Tadema, Cees G M Kallenberg, Coen A Stegeman, et al.
Autoimmunity Reviews|August 23, 2011
Immune regulatory mechanisms in ANCA-associated vasculitidesNikola Lepse, Wayel H Abdulahad, Cees G M Kallenberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2013
Pathogenesis of ANCA-associated vasculitis: new possibilities for interventionCees G M Kallenberg, Coen A Stegeman, Wayel H Abdulahad, et al.
The American Journal of Pathology|January 4, 2007
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodiesHong Xiao, Adrian Schreiber, Peter Heeringa, et al.
Antioxidants & Redox Signaling|July 23, 2009
Myeloperoxidase: molecular mechanisms of action and their relevance to human health and diseaseBetty S van der Veen, Menno P J de Winther, Peter Heeringa
Plos One|April 13, 2011
Beneficial effects of alternate dietary regimen on liver inflammation, atherosclerosis and renal activationPeter Y Wielinga, Gopala K Yakala, Peter Heeringa, et al.
Arthritis Research & Therapy|June 16, 2017
Chemokine receptor co-expression reveals aberrantly distributed T<sub>H</sub> effector memory cells in GPA patientsLucas L Lintermans, Abraham Rutgers, Coen A Stegeman, et al.
Cells|June 2, 2021
B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B CellsCarlo G Bonasia, Wayel H Abdulahad, Abraham Rutgers, et al.
Frontiers in Immunology|October 16, 2023
Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA riseIwona Wojcik, Manfred Wuhrer, Peter Heeringa, et al.
Pageof 18

Showing results (21-30 of 171) with videos related to

Sort By:
Pageof 18
Rheumatology (Oxford, England)|March 12, 2025
Highlights from the plenary session: cellular and molecular mechanisms of disease (I)Jonas Zimmermann, Adrian Schreiber, Peter Heeringa, et al.
Plos One|March 26, 2011
Reactivity against complementary proteinase-3 is not increased in patients with PR3-ANCA-associated vasculitisHenko Tadema, Cees G M Kallenberg, Coen A Stegeman, et al.
Autoimmunity Reviews|August 23, 2011
Immune regulatory mechanisms in ANCA-associated vasculitidesNikola Lepse, Wayel H Abdulahad, Cees G M Kallenberg, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 2, 2013
Pathogenesis of ANCA-associated vasculitis: new possibilities for interventionCees G M Kallenberg, Coen A Stegeman, Wayel H Abdulahad, et al.
The American Journal of Pathology|January 4, 2007
Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodiesHong Xiao, Adrian Schreiber, Peter Heeringa, et al.
Antioxidants & Redox Signaling|July 23, 2009
Myeloperoxidase: molecular mechanisms of action and their relevance to human health and diseaseBetty S van der Veen, Menno P J de Winther, Peter Heeringa
Plos One|April 13, 2011
Beneficial effects of alternate dietary regimen on liver inflammation, atherosclerosis and renal activationPeter Y Wielinga, Gopala K Yakala, Peter Heeringa, et al.
Arthritis Research & Therapy|June 16, 2017
Chemokine receptor co-expression reveals aberrantly distributed T<sub>H</sub> effector memory cells in GPA patientsLucas L Lintermans, Abraham Rutgers, Coen A Stegeman, et al.
Cells|June 2, 2021
B Cell Activation and Escape of Tolerance Checkpoints: Recent Insights from Studying Autoreactive B CellsCarlo G Bonasia, Wayel H Abdulahad, Abraham Rutgers, et al.
Frontiers in Immunology|October 16, 2023
Specific IgG glycosylation differences precede relapse in PR3-ANCA associated vasculitis patients with and without ANCA riseIwona Wojcik, Manfred Wuhrer, Peter Heeringa, et al.
Pageof 18